Dr. Dwaraka Ranganathan
Claim this profileRoyal Brisbane & Women's Hospital
More about Dwaraka Ranganathan
Clinical Trial Related
5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Dwaraka Ranganathan has experience with
- Atrasentan
- Placebo
Breakdown of trials Dwaraka Ranganathan has run
Chronic Kidney Disease
IgA Nephropathy
Immunoglobulin A Nephropathy
Urinary Tract Diseases
Acute Glomerulonephritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dwaraka Ranganathan specialize in?
Dwaraka Ranganathan focuses on Chronic Kidney Disease and IgA Nephropathy. In particular, much of their work with Chronic Kidney Disease has involved treating patients, or patients who are undergoing treatment.
Is Dwaraka Ranganathan currently recruiting for clinical trials?
No, Dwaraka Ranganathan is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Dwaraka Ranganathan has studied deeply?
Yes, Dwaraka Ranganathan has studied treatments such as Atrasentan, Placebo.
What is the best way to schedule an appointment with Dwaraka Ranganathan?
Apply for one of the trials that Dwaraka Ranganathan is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.